technetium tc 99m etidronate has been researched along with technetium tc 99m hydroxymethylene diphosphonate in 6 studies
| Studies (technetium tc 99m etidronate) | Trials (technetium tc 99m etidronate) | Recent Studies (post-2010) (technetium tc 99m etidronate) | Studies (technetium tc 99m hydroxymethylene diphosphonate) | Trials (technetium tc 99m hydroxymethylene diphosphonate) | Recent Studies (post-2010) (technetium tc 99m hydroxymethylene diphosphonate) |
|---|---|---|---|---|---|
| 96 | 3 | 2 | 618 | 35 | 87 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jonge, FA; Hamdy, NA; Pauwels, EK | 1 |
| Coffey, JL; London, J; Makler, PT; Thomas, SR; Watson, EE; Weber, DA | 1 |
| Fogelman, I | 1 |
| Barnett, BL; Benedict, JJ; Bevan, JA; Francis, MD; Tofe, AJ | 2 |
| Bevan, JA; Ferguson, DL; Francis, MD; Michaels, SE; Tofe, AJ | 1 |
1 review(s) available for technetium tc 99m etidronate and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Topics: Amyloidosis; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Etidronic Acid; Humans; Kidney Failure, Chronic; Organotechnetium Compounds; Radionuclide Imaging; Renal Dialysis; Technetium Tc 99m Medronate | 1991 |
5 other study(ies) available for technetium tc 99m etidronate and technetium tc 99m hydroxymethylene diphosphonate
| Article | Year |
|---|---|
Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Topics: Bone and Bones; Diphosphates; Etidronic Acid; Humans; Organotechnetium Compounds; Radiation Dosage; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate | 1989 |
Diphosphonate bone scanning agents--current concepts.
Topics: Bone Diseases; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Organotechnetium Compounds; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate | 1982 |
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Topics: Acute Disease; Animals; Bone and Bones; Diphosphates; Diphosphonates; Dogs; Etidronic Acid; Guinea Pigs; Injections, Intravenous; Myocardial Infarction; Organotechnetium Compounds; Radionuclide Imaging; Rats; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate; Time Factors; Tissue Distribution | 1980 |
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Topics: Animals; Bone and Bones; Diphosphates; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Femur; Myocardial Infarction; Organotechnetium Compounds; Radionuclide Imaging; Ribs; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate; Tissue Distribution | 1980 |
Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Topics: Adsorption; Animals; Bone and Bones; Calcium Phosphates; Chemical Phenomena; Chemistry; Diphosphonates; Etidronic Acid; Hydroxyapatites; Organotechnetium Compounds; Osteogenesis; Radionuclide Imaging; Rats; Technetium; Technetium Tc 99m Medronate; Time Factors; Tin; Tissue Distribution | 1980 |